Health & Behavior

Research

The Latest

Preterm Babies at Risk for Later Cognitive Difficulties

Researchers at the University of California, San Diego have received a five-year, $3 million grant from the Eunice Kennedy Shriver Institute of Child Health and Human Development, part of the National Institutes of Health. The grant will fund a longitudinal study designed to track the developmental trajectory in cognitive, academic and brain measures as very preterm children transition from preschool to grade school. Results will provide the foundation for designing appropriate learning interventions.

New Electron Beam Writer Enables Next-Gen Biomedical and Information Technologies

The new electron beam writer housed in the Nano3 cleanroom facility at the Qualcomm Institute is important for electrical engineering professor Shadi Dayeh’s two major areas of research.

European and U.S. Researchers Map Plans for Studying the Human Brain

In a first-of-its-kind academic forum, an international audience of more than 60 distinguished scientists gathered at the University of California, San Diego to discuss the future of brain-mapping research and trans-Atlantic collaborations.

Marines to be Briefed at UC San Diego before Leaving for Middle East and North Africa

Officers from Camp Pendleton’s 1st Battalion, 4th Marines will be participating in a pre-deployment educational briefing on Aug. 12, just days before leaving for tours of duty in the Middle East and North Africa.

Why Don’t We All Get Alzheimer’s Disease?

Researchers at the University of California, San Diego School of Medicine offer an explanation for why we all don't get Alzheimer's disease (AD) - a trick of nature that in most people maintains critical separation between a protein and an enzyme that, when combined, trigger the progressive cell degeneration and death characteristic of AD.

Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer

Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumors.